Zurich, Switzerland

Jiemin Du

This inventor holds 1 USPTO granted patent. Top assignee: ETH Zurich. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiemin Du. Retrieved from https://idiyas.com/inventor/jiemin-du

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jiemin Du: Innovator in Bacterial Infection Treatment

Introduction

Jiemin Du is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of medicine, particularly in the area of bacterial infections and their treatment. His innovative work has led to the development of a unique patent that addresses critical challenges in this domain.

Latest Patents

Jiemin Du holds a patent titled "Bacteriophages producing heterologous bacteriocins." This invention focuses on utilizing bacteriophages to produce bacteriocins that can combat bacterial infections effectively. The patent highlights the potential for new treatment options in medicine, specifically targeting bacterial infections.

Career Highlights

Jiemin Du is affiliated with ETH Zurich, a leading research institution known for its cutting-edge advancements in science and technology. His work at ETH Zurich has positioned him as a key figure in the research community, contributing to the understanding and treatment of bacterial infections.

Collaborations

Throughout his career, Jiemin Du has collaborated with notable colleagues, including Samuel Nando Kilcher and Matthew Stephen Dunne. These collaborations have further enriched his research and expanded the impact of his innovations in the field.

Conclusion

Jiemin Du's contributions to the field of bacterial infection treatment through his patent and work at ETH Zurich exemplify the importance of innovation in medicine. His efforts continue to pave the way for new therapeutic approaches to combat bacterial infections effectively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…